114 related articles for article (PubMed ID: 1825111)
1. Effect of coronary occlusion and myocardial viability on myocardial activity of technetium-99m-sestamibi.
Freeman I; Grunwald AM; Hoory S; Bodenheimer MM
J Nucl Med; 1991 Feb; 32(2):292-8. PubMed ID: 1825111
[TBL] [Abstract][Full Text] [Related]
2. Technetium-99m-sestamibi: another window on myocardial viability?
Liu P
J Nucl Med; 1991 Feb; 32(2):298-9. PubMed ID: 1825112
[No Abstract] [Full Text] [Related]
3. Myocardial redistribution of technetium-99m-methoxyisobutyl isonitrile (SESTAMIBI).
Li QS; Solot G; Frank TL; Wagner HN; Becker LC
J Nucl Med; 1990 Jun; 31(6):1069-76. PubMed ID: 2140856
[TBL] [Abstract][Full Text] [Related]
4. Quantification of area at risk during coronary occlusion and degree of myocardial salvage after reperfusion with technetium-99m methoxyisobutyl isonitrile.
Sinusas AJ; Trautman KA; Bergin JD; Watson DD; Ruiz M; Smith WH; Beller GA
Circulation; 1990 Oct; 82(4):1424-37. PubMed ID: 2401074
[TBL] [Abstract][Full Text] [Related]
5. The effect of collateral flow and myocardial viability on the distribution of technetium-99m sestamibi in a closed-chest model of coronary occlusion and reperfusion.
Chareonthaitawee P; O'Connor MK; Gibbons RJ; Ritman EL; Christian TF
Eur J Nucl Med; 2000 May; 27(5):508-16. PubMed ID: 10853805
[TBL] [Abstract][Full Text] [Related]
6. 99mTc-sestamibi uptake and retention during myocardial ischemia and reperfusion.
Beller GA; Glover DK; Edwards NC; Ruiz M; Simanis JP; Watson DD
Circulation; 1993 Jun; 87(6):2033-42. PubMed ID: 8504518
[TBL] [Abstract][Full Text] [Related]
7. Myocardial uptake of 99mTc-tetrofosmin, sestamibi, and 201Tl in a model of acute coronary reperfusion.
Takahashi N; Reinhardt CP; Marcel R; Leppo JA
Circulation; 1996 Nov; 94(10):2605-13. PubMed ID: 8921807
[TBL] [Abstract][Full Text] [Related]
8. Myocardial technetium-99m-tetrofosmin and technetium-99m-sestamibi kinetics in normal subjects and patients with coronary artery disease.
Münch G; Neverve J; Matsunari I; Schröter G; Schwaiger M
J Nucl Med; 1997 Mar; 38(3):428-32. PubMed ID: 9074532
[TBL] [Abstract][Full Text] [Related]
9. Experimental studies of the physiologic properties of technetium-99m isonitriles.
Beller GA; Sinusas AJ
Am J Cardiol; 1990 Oct; 66(13):5E-8E. PubMed ID: 2145747
[TBL] [Abstract][Full Text] [Related]
10. Physiological basis of myocardial perfusion imaging with the technetium 99m agents.
Beller GA; Watson DD
Semin Nucl Med; 1991 Jul; 21(3):173-81. PubMed ID: 1835136
[TBL] [Abstract][Full Text] [Related]
11. Tc-99m sestamibi defect magnitude predicts the amount of viable myocardium after coronary reperfusion despite the presence of severe residual stenosis.
Takehana K; Ruiz M; Petruzella FD; Watson DD; Beller GA; Glover DK
J Nucl Cardiol; 2001; 8(1):40-8. PubMed ID: 11182708
[TBL] [Abstract][Full Text] [Related]
12. Time course of technetium-99m sestamibi myocardial distribution in dogs with a permanent or transient coronary occlusion.
Merhi Y; Arsenault A; Latour JG
Eur J Nucl Med; 1994 Jun; 21(6):481-7. PubMed ID: 8082660
[TBL] [Abstract][Full Text] [Related]
13. Myocardial technetium-99m-teboroxime activity in acute coronary artery occlusion and reperfusion: relation to myocardial blood flow and viability.
Abraham SA; Mirecki FN; Levine D; Nunn AD; Strauss HW; Gewirtz H
J Nucl Med; 1995 Jun; 36(6):1062-8. PubMed ID: 7769429
[TBL] [Abstract][Full Text] [Related]
14. [Thallium-201 and sestamibi: principles and kinetics of the two tracers].
Parodi O
G Ital Cardiol; 1991 Aug; 21(8):885-8. PubMed ID: 1837528
[No Abstract] [Full Text] [Related]
15. Myocardial transport of hexakis(2-methoxyisobutylisonitrile) and thallium before and after coronary reperfusion.
Meerdink DJ; Leppo JA
Circ Res; 1990 Jun; 66(6):1738-46. PubMed ID: 2140539
[TBL] [Abstract][Full Text] [Related]
16. Advances in myocardial perfusion imaging: 99mTc-teboroxime.
Pieri PL; Strauss HW
J Nucl Biol Med (1991); 1992; 36(2 Suppl):22-8. PubMed ID: 1450239
[No Abstract] [Full Text] [Related]
17. Prediction of myocardial viability: Tl-201 versus sestamibi versus teboroxime compared with FDG uptake.
Kiser JW; Drane WE; Mastin ST; Nicole MW
Clin Nucl Med; 1998 Jul; 23(7):432-6. PubMed ID: 9676947
[TBL] [Abstract][Full Text] [Related]
18. Area-at-risk determination by technetium-99m-hexakis-2-methoxyisobutyl isonitrile in experimental reperfused myocardial infarction.
De Coster PM; Wijns W; Cauwe F; Robert A; Beckers C; Melin JA
Circulation; 1990 Dec; 82(6):2152-62. PubMed ID: 2242539
[TBL] [Abstract][Full Text] [Related]
19. Myocardial kinetics of 99m technetium-Q agents: studies in isolated cardiac myocyte, isolated perfused rat heart, and canine regional myocardial ischemia models.
McGoron AJ; Biniakiewicz D; Millard RW; Kumar A; Kennedy SC; Roszell NJ; Gabel M; Huth C; Walsh RA; Gerson MC
Invest Radiol; 1999 Nov; 34(11):704-17. PubMed ID: 10548383
[TBL] [Abstract][Full Text] [Related]
20. Myocardial technetium 99m sestamibi kinetics after reperfusion in a canine model.
Glover DK; Okada RD
Am Heart J; 1993 Mar; 125(3):657-66. PubMed ID: 8438693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
